Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 70,874 | 71,681 | 93,973 | 58,879 | 52,443 |
| Cost of Goods | 18,708 | 18,224 | 18,157 | 17,999 | 16,979 |
| Gross Profit | 52,166 | 53,457 | 75,816 | 40,880 | 35,464 |
| Operating Expenses | 72,080 | 66,454 | 65,683 | 66,915 | 66,047 |
| Operating Income | -19,206 | -12,773 | 10,290 | -25,036 | -29,604 |
| Interest Expense | 2,889 | 2,954 | 2,971 | 2,948 | 2,905 |
| Other Income | 2,080 | 2,148 | 2,226 | 2,391 | 2,679 |
| Pre-tax Income | -20,015 | -13,579 | 9,545 | -25,593 | -29,830 |
| Net Income Continuous | -20,015 | -13,579 | 9,545 | -25,593 | -29,830 |
| Minority Interests | 18 | 0 | -1 | 21 | 22 |
| Net Income | $-20,033 | $-13,579 | $9,546 | $-25,614 | $-29,852 |
| EPS Basic Total Ops | -0.13 | -0.08 | 0.06 | -0.17 | -0.20 |
| EPS Basic Continuous Ops | -0.13 | -0.09 | 0.06 | -0.17 | -0.20 |
| EPS Diluted Total Ops | -0.13 | -0.08 | 0.06 | -0.17 | -0.20 |
| EPS Diluted Continuous Ops | -0.13 | -0.08 | 0.06 | -0.17 | -0.20 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.09 | -0.15 | -0.17 | -0.20 |
| EBITDA(a) | $-15,505 | $-8,866 | $14,179 | $-21,284 | $-25,831 |